{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/181606290"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "DNA Stool Test In August 2014, the US Food and Drug Administration (FDA) approved Cologuard, the first stool-based bowel cancer screening test that detects the presence of red blood cells and DNA mutations that may indicate the presence of certain kinds of abnormal growths that may be cancers such as bowel cancer or precursors to cancer." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "bowelcanceraustralia.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/394922320"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/181606290" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/135062563"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/181606290"] } } }
